Shifting paradigms and bridging gaps

EVBio evangelizes a paradigm shift in endothelial cells mechanobiology to bridge the gaps between vascular hemodynamics and pathophysiologic disease models

Basic Research

EVBio supports and promotes new paradigms in endothelial cells research. Future research should discover hidden mechanotransductive pathways using new experimental approaches that accurately mimic human physiopathology

Translational Research

Translational research bridges the gaps between biomechanics and mechanobiology. Our members are active experts in bioengineering, biomedical engineering, vascular surgery and molecular biology. They work together to break the silos and bridge the gaps in vascular medicine.

Featured news

Browse All

RapidPulse Closes Series A Financing to Support Ischemic Stroke Therapy
June 23, 2021—RapidPulse, Inc. announced the closing of a $15 million Series …
Penumbra’s Red 62 Reperfusion Catheter Cleared by FDA
June 23, 2021—Penumbra, Inc. announced FDA 510(k) clearance and commercial availability of …
Sensome’s Clotild AI-Powered Stroke Guidewire Receives FDA Breakthrough Device Designation
June 21, 2021—Sensome announced that it has been granted a Breakthrough Device …
First patient treated in the BeGraft FEVAR study aimed at providing evidence for on-label use
On 19 March, the first patient was included in the BeGraft fenestrated …
Sectoral Asset Management makes US$9 million investment into Cagent Vascular
Cagent Vascular recently announced the investment of US$9 million by Sectoral Asset …

EVBio calls for a universal theory of vascular disease where mechanobiology and hemodynamics are connected in one explanatory framework

– Khalid Saqr, EVBio founder